Sarepta Therapeutics, Inc. et al. vs. Genzyme Corporation et al.

Explore the PTAB proceeding IPR2025-01194 filed by Sarepta Therapeutics, Inc. et al. on 2025-06-26. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2025-01194

Filing Date

2025-06-26

Accorded Filing Date

2025-06-26

Institution Decision Date

2025-11-20

Last Modified Date

2025-12-23

Proceeding Type

IPR

Termination Date

2025-11-20

Trial Status

Discretionary Denial

Parties & Counsel

Petitioner

Sarepta Therapeutics, Inc. et al.

Represented By

Wilson, Robertet al

Patent Owner / Respondent

Genzyme Corporation et al.

Represented By

Antons, Amandaet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 12661553

Respondent Patent Number 9051542

External Links

Espacenet

Google Patents

Respondent Inventor John Fraser Wright et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

40 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name LISA P. RASMUSSEN - SANOFI

Customer Number 5487

Address 450 WATER STREET, Cambridge, MA, 02141, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
36844	Joseph Kirk Jr	908-981-6911
39150	John Conway	908-981-6688
40564	Anne Collins	978-341-0036
44045	Sandra Brockman-Lee	857-523-9199
45736	Pamela Torpey	508--27-1-0683
45979	Milan Vinnola	619-238-0062
47150	Nicole Parsons	617-685-5697
52610	Kelly Bender	2485930581
54154	Allyson Hatton	508-361-7392
54958	Janann Ali	617-685-5645
58163	Alejandro Martinez	617-685-5935
59682	Jeremy Bond	617-685-5653
61358	Ryan Mcquade	617-838-5595
61393	Isaac Hubner	617-866-4544
62108	Siew Chong	973-980-0397
63001	Stephanie Donahue	908-331-4406
63750	Mayssam Ali	617-685-5646
64259	Xuemei Peng	908-981-6951
64740	Alan Townsley	202-857-2278
64828	Jeffrey Weber	617-685-6431
66863	Patricia Callanan	617-866-4404
67265	Yi Wang	617-685-5735
67340	Dhruv Kaushal	617-245-4065
68308	Jonathan Andron	617-685-5658
68315	Meenakshy Chakravorty	781-418-9211
69032	Robert Bolcome Iii	857-331-1597
69052	Jing Wang	617-951-8720
69953	Janet Tse	617-564-6571
70740	Erika Wallace	617-937-1397
71226	Meghan Klaric	313-465-7211
72110	Daniel Tate	800-981-2491
72475	Indrani Dasgupta	617-685-5977
72868	David Lefebvre	617-685-5338
72919	Ted Ririe	385-312-6536
74124	Evan King	781-234-4286
75427	Shirley Tan	617-646-8444
77001	Sara Haines	003-348-1492783
80264	Christopher Marion	314-517-7022
80424	Victoria Pedanou	508-736-4409
81386	Erin May	617-251-9709

Proceeding Documents

144

Notice: refund approved NOTICE

2025-12-05 FILING PARTY: BOARD

Download

Refund Request OTHER

2025-12-04 FILING PARTY: PETITIONER

Download

Director Discretionary Decision: Deny RESPONSE

2025-11-20 FILING PARTY: BOARD

Download

Institution Decision: Deny DECISION

2025-11-06 FILING PARTY: BOARD

Download

Sur-Reply to PO's Reply to Discretionary Denial OTHER

2025-10-22 FILING PARTY: PETITIONER

Download

Sarepta Therapeutics, Inc. et al. vs. Genzyme Corporation et al.

Proceeding Overview

Parties & Counsel

Petitioner

Sarepta Therapeutics, Inc. et al.

Represented By

Patent Owner / Respondent

Genzyme Corporation et al.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Notice: refund approved NOTICE

Refund Request OTHER

Director Discretionary Decision: Deny RESPONSE

Institution Decision: Deny DECISION

Sur-Reply to PO's Reply to Discretionary Denial OTHER

Patent Owner's Reply to Petitioner's Opposition to Patent Owner's Request for Discretionary Denial OTHER

Email re Novartis v. Genzyme Exhibit

Email Correspondence Exhibit

Ex. 1090 Exhibit

Ex. 1086 Exhibit

Discretionary Denial Opposition RESPONSE

Ex. 1088 Exhibit

Jia 2010 Exhibit

WO1999041416A2 Exhibit

Croyle-Development of formulations Exhibit

Arista Romano Exhibit

Martyn Davies CV Exhibit

Biotechnology Progress, Vol 21, No 2 2005 Exhibit

Remington Chapter 87 Exhibit

Ex. 1085 Exhibit

Ayache Exhibit

Ex. 1089 Exhibit

Remington Chapter 17, 18, 23, 36 Exhibit

Aaron 2023 Exhibit

Patent Owner's Preliminary Response POPR

Gatlin-Formulation and Administration Exhibit

Declaration of Martyn C. Davies Exhibit

Ex. 1087 Exhibit

Chu 2016 Exhibit

Booy et al Exhibit

A.E. Smith, Gene Therapy Where Are We Exhibit

Ex. 1091 Exhibit

Ex. 1092 Exhibit

Adevoh Exhibit

Ex. 1084 Exhibit

Carpenter-Rational Design of Stable Protein Formulations Exhibit

Ex 3001 Exhibit

Patent Owner's Updated Mandatory Notices NOTICE

Notice of Service of Plaintiff’s Initial Claim Chart in Genzyme Corporation v. Sarepta Therapeutics, Inc. Exhibit

Declaration of Katherine A. Helm In Support of Admission Pro Hac Vice Exhibit

Exhibit K For Dkt. No. 81 in Genzyme Corporation v. Sarepta Therapeutics, Inc., and Sarepta Therapeutics Three, LLC Exhibit

Notice of Intent to Designate Katherine A. Helm as Backup Counsel OTHER

Ansell Heatlhcare Prods. LLC v. Reckitt Benckiser LLC, 15-cv-915-RGA, Dkt. No. 105 Exhibit

RainDance Techs., Inc. v. 10X Genomics, Inc., 15-cv-152-RGA, Dkt. No. 27 Exhibit

Oral Order on April 5, 2016 Denying Motion to Stay in RainDance Technologies, Inc. et al v. 10X Genomics, Inc. 1-15-cv-00152 Exhibit

Avoid Using Phosphate Buffered Saline (PBS) as an Electrolyte for Accurate OER Studies Exhibit

Second Amended Complaint in Genzyme Corporation v. Sarepta Therapeutics, Inc., and Sarepta Therapeutics Three, LLC Exhibit

Exhibit M For Dkt. No. 81 in Genzyme Corporation v. Sarepta Therapeutics, Inc., and Sarepta Therapeutics Three, LLC Exhibit

Collabo Innovations, Inc. v. Sony Corp., 15-cv-1094-RGA, Dkt. No. 43 Exhibit

Notice of Service of Stipulation to Extend Time in Genzyme Corporation v. Sarepta Therapeutics, Inc., and Sarepta Therapeutics Three, LLC Exhibit

Patent Owner's Request for Discretionary Denial RESPONSE

Complaint in Genzyme Corporation v. Sarepta Therapeutics, Inc. Exhibit

Notices of Service for Interrogatories and Requests for Production in Genzyme Corporation v. Sarepta Therapeutics, Inc., and Sarepta Therapeutics Three, LLC Exhibit

So Ordered re 77 Joint Stipulation to Amend Scheduling Order in Genzyme Corporation v. Sarepta Therapeutics, Inc., and Sarepta Therapeutics Three, LLC Exhibit

Sotera Stipulation OTHER

Notice: Mandatory Notice NOTICE

Notice: Power of Attorney NOTICE

Notice: Notice filing date accorded NOTICE

Ex. 1013 Exhibit

Ex. 1016 Exhibit

Ex. 1009 Exhibit

Ex. 1041 Exhibit

Ex. 1042 Exhibit

Ex. 1076 Exhibit

Ex. 1040 Exhibit